- This systematic evidence map screened 6,805 PubMed and Embase records and included 1,116 studies, mostly adult cohort studies in critically ill patients.
- It mapped novel kidney biomarkers for AKI by purpose: prediction (n = 944), prognosis (n = 647), etiology (n = 109), trial enrichment (n = 6), and management (n = 12).
- Accuracy studies comparing biomarkers with AKI diagnosis were far more common than practical trials of biomarkers in clinical use.
- The authors suggest implementation guidance can be drawn mainly from surgical and nephrotoxin-exposed populations, where evidence is available.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Prospective randomized controlled trial of 254 children aged 3-9 years undergoing elective adenotonsillectomy.
- Children were intubated with a room-temperature polyvinyl chloride endotracheal tube or one softened and pre-warmed to 37°C.
- Overall perioperative respiratory adverse events were 14.1% with warmed tubes versus 24.6% with room-temperature tubes (p = 0.039), with lower laryngospasm and postoperative coughing.
- Room-temperature tube use was an independent predictor (adjusted OR 2.29, 95% CI 1.16-4.54); the authors call for multicenter confirmation.
- Matched cohort study using TriNetX data, with 1262 propensity-matched adults per group undergoing primary THA from 2003 to 2023.
- Patients with at least three GLP-1 receptor agonist prescriptions within one year before surgery were compared with matched controls.
- At 90 days, GLP-1 RA users had lower DVT (1.6% vs 3.0%; RR 0.53, 95% CI 0.31-0.89; p=0.014) and readmission (1.1% vs 2.8%; RR 0.40, 95% CI 0.22-0.71; p=0.001).
- No significant differences were seen in other 90-day outcomes or in 5-year mechanical outcomes, such as PJI and all-cause revision survival.
- Prospective multicentre observational cohort across 21 UK NHS hospitals, enrolling 13,646 adults undergoing common surgical procedures.
- Compared patients with at least one drug allergy label (3924) against those without (9722) for a composite of 30-day postoperative complications.
- Labelled patients had more complications (25% vs 20%; OR 1.21 [1.10-1.34]; P<0.001) and more postoperative infections (19% vs 15%; OR 1.24 [1.11-1.38]; P<0.001).
- Allergic drug reactions were more frequent in labelled patients (OR 3.00 [1.77-5.09]) with no increase in mortality; the authors note labels are common but often incorrect.
- A prospective observational African cohort of 10,748 adult perioperative patients from 2016 was analyzed for 30-day in-hospital mortality.
- A logistic mixed-effects model, adjusted for patient and surgical factors, estimated the association of each severe postoperative complication with death and its attributable fraction.
- The highest adjusted ORs were for pulmonary embolism (OR 484; 95% CI 85.2-2744), pulmonary edema (OR 53.5), and bloodstream infections (OR 34.3), among 222 deaths (2.07%).
- Severe bloodstream infections had the largest average attributable fraction for 30-day mortality at 13.7% (95% CI 10-18.1), which the authors identify as a priority to address.
- This cross-sectional study used up to 472,279 UK Biobank participants to relate surgical procedures in the prior 1, 3, and 5 years to biological aging.
- Biological age was measured as PhenoAge acceleration from clinical biomarkers and as leukocyte telomere length, with multivariable linear regression for the number of surgeries.
- Each additional surgery was associated with 0.46 (95% CI, 0.43-0.49), 0.26 (0.24-0.27), and 0.20 (0.19-0.21) years higher PhenoAge acceleration for the 1-, 3-, and 5-year windows.
- Telomere length associations had confidence intervals spanning zero, and the authors describe the PhenoAge effects as modest, stronger with higher-stress surgery and frailty or comorbidity.
- Retrospective comparative observational study of 196 patients (98 per group) undergoing high-definition lipoabdominoplasty under general anesthesia.
- Group A received semaglutide or tirzepatide, while Group B received no GLP-1 receptor agonist therapy.
- No statistically significant between-group differences were found in intraoperative adverse events, recovery times, nausea and vomiting, pain scores, or early complications; the abstract gives no effect sizes or p values.
- The authors state these null findings do not show equivalence, since the study was not designed for non-inferiority testing and may be underpowered for rare events.
- A prospective multicentre cohort at seven Dutch hospitals enrolled 103 frail patients (mean age 87) who chose non-operative management of hip fracture.
- All patients received an ultrasound-guided pericapsular nerve group block with phenol 6% (mean 10 ml), with a second needle needed in 14%; there was no comparator group.
- At 1 week, 34/36 (94%) reported acceptable pain at rest, and 24/53 (45%) could transfer from bed to chair.
- Three-month mortality was 72/91 (79%), with median survival of 9 days; the authors describe the block as an effective add-on analgesic.
- This narrative review draws on PubMed, Google Scholar, reference lists, and intrathecal pump device manuals to cover perioperative, obstetric, and ICU care of patients with implanted intrathecal drug delivery systems.
- It is organized into five sections: intrathecal pharmacology, implantation considerations, perioperative care, neuraxial anesthesia, and device-related safety concerns.
- Where evidence is limited, the authors supplement the literature with expert opinion, so some recommendations rest on consensus rather than data.
- The authors highlight intrathecal medications, their behavior under MRI, and precautions before any neuraxial access in these patients.
- This practical guide synthesizes evidence, consensus recommendations, and international clinical experience on intrathecal drug delivery for refractory pain.
- It covers preimplant evaluation, trialing, pump and catheter selection, perioperative care, early troubleshooting, long-term maintenance, and complication surveillance.
- It reviews intrathecal opioids, local anesthetics, ziconotide, clonidine, and baclofen, with attention to indication-specific dosing and safety, but reports no pooled quantitative results.
- It frames outcomes beyond pain intensity, including function, quality of life, and reduced systemic medication use, and addresses cancer and non-cancer populations separately.
- Retrospective single-center study of 215 patients with chronic non-cancer pain who received intrathecal drug delivery devices between 2009 and 2022, most with PSPS2 (184 patients).
- The exposure was intrathecal drug delivery, and explant reasons were compared with spinal cord stimulation explant rates from a similar patient population.
- The explant rate was 26.1%, with device-related infection the leading cause in 9.3% of patients (5.9% of device surgeries) and loss of analgesic efficacy in 5.6%.
- Infections occurred earlier after implant than other complications, and no demographic or comorbidity factors correlated with explant, per the authors.
- Retrospective TriNetX cohort of adults undergoing ACDF; the primary high-dose versus standard-dose comparison included 921 propensity-matched patients per arm.
- Exposure was the GLP-1 receptor agonist prescription strength recorded from 1 year to 1 week before surgery, comparing high-dose with standard-dose use.
- Ninety-day readmission was 11.4% versus 10.0% (p=.327), and opioid exposure was 85.2% versus 83.1% (p=.202), with no significant differences in complications or fusion outcomes.
- Both standard-dose and high-dose users had lower pseudarthrosis rates than nonusers, but higher dose added no further long-term benefit, and the authors conclude high-dose therapy does not add perioperative or fusion risk.
- Systematic review and meta-analysis of 27 randomized controlled trials including 3041 patients undergoing surgery, searched from inception to December 2025.
- Perioperative vitamin C was compared with control; the review pooled effects on pain, opioid use, rescue analgesia, nausea and vomiting, and CRPS-1.
- Vitamin C reduced pain at 24 h (SMD -0.69, 95% CI -0.98 to -0.40) and 24-h morphine use (MD -4.25 mg, 95% CI -6.14 to -2.35), with rescue analgesia also reduced (RR 0.63, 95% CI 0.47 to 0.84).
- Authors say evidence may support reduced acute pain and opioid use with a favorable safety profile, but heterogeneity and publication bias limit it, and routine recommendation is not yet supported; CRPS-1 risk was lower in high-risk orthopedic patients (RR 0.36, 95% CI 0.23 to 0.58).
- This retrospective TriNetX database study propensity-matched 1:1 GLP-1 RA users with non-user controls undergoing total knee arthroplasty, tracking outcomes over 2 years.
- The exposure was GLP-1 RA use within the year before TKA, compared with non-users, with laterality assessed to attribute complications to the operated knee.
- PJI was lower in users (1.5% vs. 2.0%; RR 0.74; 95% CI 0.57 to 0.96; P = 0.02), and the difference persisted among diabetic patients (RR 0.68; 95% CI 0.52 to 0.89; P < 0.01).
- Revision, mechanical loosening, periprosthetic fracture, and other mechanical complications did not differ, which the authors interpret as a selective effect against infection.
- Multicenter longitudinal study of 370 patients aged 65 or older undergoing elective non-cardiac surgery at two academic hospitals, with QoL measured preoperatively and at 30 and 90 days.
- Preoperative cognitive impairment was defined by the AD8, with MoCA and Mini-Cog also used, and QoL was rated on a 0-100 visual analogue scale.
- Patients with AD8-defined impairment had lower QoL at all timepoints (preoperative 67 ± 3 vs. 78 ± 1; 30 days 59 ± 3 vs. 75 ± 1; 90 days 60 ± 3 vs. 77 ± 1; all P < 0.001), but trajectories did not differ significantly.
- Lower preoperative QoL was associated with complications, non-home discharge, and composite adverse outcomes, and the authors suggest brief preoperative screening may help identify at-risk patients.
- Multicenter retrospective cohort using Epic Cosmos data from 2016 to 2025, including 38,433 adults undergoing elective below-knee amputation.
- Compared 7,430 patients who received perioperative nerve blocks with 31,003 who did not, examining phantom limb syndrome coded within 12 months.
- Phantom limb syndrome coding occurred in 18.8% versus 15.1% (absolute difference 3.7%), with Mantel-Haenszel RR 1.24 (95% CI 1.20 to 1.28) after age, sex, and race adjustment.
- The authors call the findings exploratory, possibly reflecting confounding by indication or differential surveillance, and report shorter length of stay with blocks.
- Systematic review and meta-analysis of 12 randomised trials (n = 739) comparing remimazolam with sevoflurane for general anaesthesia maintenance or deep sedation.
- Remimazolam was compared with sevoflurane, with outcomes covering intraoperative haemodynamic stability and postoperative nausea and vomiting.
- Remimazolam reduced the risk of intraoperative hypotension versus sevoflurane, RR 0.38 (95% CI 0.25 to 0.57; P < 0.001).
- MAP and heart rate differences appeared only at specific time points, and the PONV reduction came from sensitivity analyses, not the primary analysis.
- Systematic review and meta-analysis of 4 RCTs (7 reports, 446 randomized adults) comparing perioperative subcutaneous liraglutide with placebo or insulin-based usual care in cardiac surgery.
- Liraglutide was compared with placebo or insulin usual care, with glycemic efficacy and hypoglycemia risk as the central questions.
- Liraglutide did not change 30-day mortality (1/161 vs 3/160; RR 0.42, 95% CI 0.06-2.81) or the composite postoperative complication outcome (RR 0.92, 95% CI 0.74-1.14).
- Hypoglycemia was similar (8/165 vs 9/166; RR 0.85, 95% CI 0.34-2.13), and nausea/vomiting estimates were very imprecise (RR 3.01, 95% CI 0.26-35.27).
- Retrospective single-centre cohort of 830 patients with diabetes undergoing primary THA or TKA from 2015 to 2022, split into insulin-dependent (351) and non-insulin-dependent (479) groups.
- The exposure was insulin dependence, compared with non-insulin-dependent diabetes, and outcomes were 90-day complications, perioperative glucose control, and mid-term reoperation.
- 90-day complications occurred in 35.9% of insulin-dependent patients versus 16.3% of others (p < 0.01), with an adjusted odds ratio of 2.81 (95% CI 1.98 to 3.98).
- Insulin dependence was also associated with poorer perioperative glucose control, while reoperation rates were similar between groups; the authors frame it as a risk marker beyond HbA1c.
- Retrospective matched-pair analysis of German Thoracic Registry data (2016–2020) from multiple centers, yielding 204 matched triplets (612 patients) after lung resections.
- Compared patients by intraoperative crystalloid volume, with subgroup analyses of wedge resections versus anatomic resections.
- Crystalloid volume of 2,500 mL or more was associated with higher overall and respiratory complications, especially pneumonia, in anatomic resections, while wedge resections showed minimal impact.
- The authors identified 2,500 mL as a critical threshold and favored a restrictive fluid approach, though nonpulmonary complications were unaffected.
- This systematic review qualitatively synthesized 23 studies, mostly retrospective cohorts and propensity-matched database analyses, in adults undergoing elective spine surgery.
- The exposure was documented preoperative or perioperative GLP-1 receptor agonist use, assessed against fusion, infection, readmission, complications, and length of stay.
- Lumbar fusion studies generally reported favorable or neutral associations, though some TLIF cohorts reported adverse ones, while cervical findings varied by surgical approach.
- No included study reported postoperative pancreatitis, and the authors stress that the findings are associations and that perioperative management should be individualized.
- This is a structured critical review of the 2024 ASIPP consensus guideline, built from literature review, evidence synthesis, and modified Delphi voting.
- It summarizes recommendations on stopping, bridging, and resuming antiplatelet and anticoagulant drugs, with 50 interventional procedures stratified by composite risk score.
- Of the 50 procedures, 19 were classed low-risk, 7 moderate-risk, and 24 high-risk, and 16 of 18 recommendations reached unanimous panel acceptance.
- The authors favor selective rather than routine cessation, especially for low-risk procedures, while acknowledging uncertainty about procedure classifications and interruption intervals.
- Single-center retrospective cohort of 2184 eligible adults aged 65 or older having major noncardiac surgery with hs-cTnT surveillance; 612 propensity-matched pairs were analyzed.
- A preoperative autonomic vulnerability phenotype (diabetes and/or hypertension plus neuropathy, orthostatic hypotension, syncope/presyncope, or unexplained bradycardia) was compared with matched controls.
- Adjudicated ischemic MINS occurred in 14.2% of the vulnerability group versus 8.7% of controls (OR 1.75; 95% CI 1.23-2.49; P = .002).
- The association strengthened with higher intraoperative hypotension burden (interaction P = .018), and 30-day MACE and 1-year mortality were also higher in the vulnerability group.
- Retrospective TriNetX database analysis of 1,092 patients undergoing quadriceps or patellar tendon repair, propensity-matched into two cohorts of 546.
- Exposure was preoperative GLP-1 receptor agonist use within one year of surgery, compared with patients without that use, followed to 90 days, 1 year, and 2 years.
- At 1 year, surgical site infection was lower with GLP-1 use (2.38% vs 5.31%; OR 0.435; P=.0118), as were wound complications (2.02% vs 5.31%; OR 0.367; P=.0037).
- No 90-day or revision surgery differences were found, and the authors suggest possible perioperative risk modulation as GLP-1 use grows.
- Observational study of 138 parents of children aged 7 to 12 after tonsillectomy, who completed smartphone diaries three times daily for 7 days.
- Exposure was parents' affect (pain catastrophizing, negative and positive affect), and the outcomes were perceived child pain and home opioid administration.
- In multilevel models, average and momentary parent affect predicted perceived child pain, while average negative affect and momentary affect predicted opioid administration odds.
- Parent pain catastrophizing had a bidirectional lagged relation with perceived child pain, and the authors suggest momentary affect assessment may capture shifts that precede escalations.
- Prospective single-center observational pilot of 122 adults with preserved renal function undergoing elective isolated on-pump CABG, grouped by routine practice.
- Patients received 20 mg IV furosemide 10-15 minutes before CPB (n = 66) or no loop diuretic before CPB (n = 56).
- Urinary oxygen tension was lower with furosemide at 20 minutes after CPB (28.7 ± 6.7 vs 35.4 ± 6.3 mmHg; p < .001) and before ICU transfer (31.0 ± 7.1 vs 39.1 ± 6.8 mmHg; p < .001), and the association persisted after adjustment.
- Postoperative creatinine, urine output, acute kidney injury incidence, and in-hospital mortality did not differ significantly, and the authors call the findings hypothesis-generating.
- A preplanned secondary analysis of a single-center, double-blind, 3-arm randomized trial in 34 adults undergoing elective CABG with cardiopulmonary bypass.
- Patients received albumin-based, gelofusine-based, or retrograde autologous priming (reference), with Stewart acid-base variables measured at five perioperative time points.
- Bypass initiation caused metabolic acidosis (-0.1 pH, -4.3 mmol/L standard base excess, -6.6 mEq/L effective strong ion difference), and these measures did not differ among priming strategies.
- Each extra liter of crystalloid independently lowered pH (-0.011; p = 0.035) and effective strong ion difference (-1.03 mEq/L; p = 0.025), which the authors attribute to crystalloid load rather than colloid choice.
- This Level III study identified 6,482 patients who had primary hip or knee arthroplasty between 2019 and February 2023.
- The exposure was preoperative GLP-1 use, which rose from 2% of patients in 2019 to 5% in 2022.
- Among GLP-1 users, mean preoperative weight change was -9 pounds, and 19% lost at least 20 pounds; multivariable models showed no link to complications (P = .85).
- GLP-1 use was not associated with revisions, reoperations, or complications, and the 90-day emergency visit odds ratio was 1.5 (P = .07).
- Systematic review and meta-analysis of 55 observational studies, with 21 contributing to the meta-analyses, in acutely admitted adult ICU patients.
- Exposure was pre-admission frailty or functional dependency, compared with non-frail or independent status.
- Non-frail versus frail participants had RR 0.62 (95% CI 0.58-0.67, P<0.01) for all-cause mortality; independent versus dependent had RR 0.47 (95% CI 0.40-0.54, P<0.01).
- The authors conclude that frailty and dependency were associated with higher mortality, but certainty of evidence was very low and heterogeneity was substantial.
- This is an expert consensus decision pathway and review, not a primary study, so it reports no enrolled patients or new outcome data.
- It updates the 2023 pathway with probability-based diagnosis, the HFpEF-ABA screening score, and a cardiovascular-kidney-metabolic framing.
- SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists are positioned as foundational therapy, with finerenone favored over steroidal agents; ARNI is selectively considered.
- The authors note that several pivotal trials enrolled patients with ejection fractions starting at 40% or 45%, and benefits were often driven by fewer worsening heart failure events rather than cardiovascular mortality.
- Systematic review and meta-analysis of 21 randomized controlled trials including 1271 adults undergoing spinal surgery.
- The exposure was perioperative intravenous magnesium sulfate, with a control group for comparison.
- Magnesium reduced 24-hour pain scores (MD -0.55, 95% CI -1.01 to -0.10, P = 0.02) and opioid consumption (MD -4.95 mg, 95% CI -8.74 to -1.15 mg, P = 0.01).
- Magnesium was associated with less postoperative nausea and vomiting but more hypotension, and with prolonged time to follow commands and recover orientation.
- Database analysis of 2345 patients with GLP-1 RA exposure undergoing ACDF (CPT 22551) in TriNetX, 2014–2024, with 1:1 propensity-matched controls.
- Exposure timing was grouped as preoperative, perioperative, or postoperative, with a landmark approach for postoperative initiators to limit immortal time bias.
- Overall use was linked to less pseudarthrosis and dysphagia but not revision; the abstract reports no odds ratios, confidence intervals, or p values.
- Continuous perioperative use was associated with more dysphagia and revision but less sepsis, while postoperative initiation was linked to less pseudarthrosis, especially in patients with diabetes.
- This focused review covers perioperative stroke in pediatric and adult patients, including epidemiology, clinical presentation, and risk factors.
- It outlines an approach to telling suspected stroke apart from lingering anesthetic neurological effects in the post-anesthesia care unit.
- The authors note that no standardized screening tool exists and suggest that weighing surgery type, medications, and patient risk factors can aid recognition.
- They conclude that PACU strokes are rare, but diagnostic delay can worsen outcomes, so suspicion should be maintained when symptoms and risk factors coexist.
- Prospective single-centre observational cohort of 420 adults aged 60 or older undergoing elective gastrointestinal cancer surgery on tertiary surgical wards.
- Exposures were nocturnal ward noise, light, and care interruptions, plus multidomain physiological measures covering sleep-circadian, autonomic, inflammatory, and gut microbial profiles.
- POD occurred in 21.4%; environmental burden was linked to delirium (adjusted OR 1.78 per SD, 95% CI 1.35 to 2.34) and resilience to lower risk (OR 0.62, 95% CI 0.48 to 0.81).
- The authors call the mediation and integrated-profile findings exploratory and hypothesis-generating, and state that external validation is needed before any causal interpretation.
- Systematic review and meta-analysis of RCTs in adults undergoing cardiac surgery with cardiopulmonary bypass; 105 trials identified, 39 pooled.
- Compared ventilation strategies across the preoperative, intraoperative and postoperative periods, with all-cause mortality as the primary outcome.
- Ventilation during bypass reduced postoperative pulmonary complications (RR 0.87, 95% CI 0.79 to 0.96; P=0.005; 15 studies).
- Postoperative noninvasive respiratory support showed a non-significant mortality trend (RR 0.60, 95% CI 0.34 to 1.08; five studies).
- Post hoc secondary analysis of two trials across 30 hospitals, including 1963 adults having major abdominal or thoracic surgery.
- Compared patients given antiemetic-dose intraoperative corticosteroids with those who did not, using inverse probability of treatment weighting for preoperative confounders.
- After weighting, steroids were not significantly associated with fewer postoperative pulmonary complications (OR 0.86, 95% CI 0.62-1.18, P=0.347), though the unweighted rates were lower (9.3% vs 14.0%).
- PACU PaO2/FiO2 ratio was modestly higher with steroids (adjusted mean difference 19.9 mm Hg, 95% CI 0.64-39.1, corrected P=0.043).
- Retrospective single-center cohort of 3,124 adults admitted intubated to a cardiac surgical ICU, analyzed with inverse probability weighting.
- Exposure was early ICU sedation-ventilation dyssynchrony within 12 hours, grouped into deep-only, light-only, or both phenotypes using RASS, CAM-ICU, blood gas and ventilator variables.
- Dyssynchrony was associated with reintubation within 72 hours of planned extubation (aOR 3.4; 95% CI, 2.5–4.6), which occurred in 5% of patients overall.
- Dyssynchrony was also linked to delirium, AF, AKI, dialysis and 30-day mortality; exploratory mediation found 41% (95% CI, 28%–54%) of the AKI association compatible with reintubation mediation.
- This narrative review synthesizes the infrastructure, devices, and implementation of remote patient monitoring across the surgical continuum.
- Before surgery, remote monitoring data are being explored for risk prediction and prehabilitation, with the aim of improving risk stratification.
- After surgery, continuous monitoring on wards and after discharge may enable earlier detection of deterioration and facilitate early discharge.
- The authors note that large clinical trials are ongoing and will provide further outcome evidence, and suggest a new subspecialty of perioperative care navigators may emerge.
- This is a review of delirium prevention and management evidence and the German S3 guideline in older adults, and it gives no sample size.
- It contrasts nonpharmacological multicomponent programs (HELP, ABCDE(F), CHOPS, AKTIVER) with pharmacological strategies.
- It cites two 2026 meta-analyses reporting a 44% reduction in delirium incidence and shorter duration once delirium was established; drug benefits were inconsistent or limited.
- The authors conclude that the S3 guideline strongly recommends structured, interdisciplinary, person-centered programs, and only dexmedetomidine showed a preventive effect in selected perioperative settings.
- Retrospective cohort of 31,979 singleton deliveries at or after 28 weeks across two Chicago hospitals, March 2018 to February 2020.
- Anemia was defined as third-trimester Hb below 11 g/dL and graded by severity, and was examined against sociodemographic factors and delivery site.
- Third-trimester anemia affected 40.2% (12,841 patients), more often in non-Hispanic Black patients (53.3%) and lower-income neighborhood residents.
- Transfusion was associated with Hispanic ethnicity (aOR 1.62), Asian race (aOR 1.42), anemia severity, cesarean delivery and site, but not non-Hispanic Black race (aOR 1.10).